An international team of researchers, led by the University of Vienna and the Helmholtz Institute for Pharmaceutical Research Saarland, has discovered saarvienin A, a new type of glycopeptide ...

The glycopeptide antibiotics (GPAs) are essential for the control of infectious disease caused by Gram-positive pathogenic bacteria. Three GPAs are in current clinical use (Figure 1 and Table 1): the ...

For glycopeptide characterization, mass spectrometry has arisen as the go-to methodology. As well as the instrumental arrangement, a suitable software solution is essential to enable glycopeptide ...

An international team of researchers, led by the University of Vienna and the Helmholtz Institute for Pharmaceutical Research Saarland, has discovered saarvienin A, a new type of glycopeptide ...

An international team of researchers has discovered saarvienin A, a new type of glycopeptide antibiotic. Their findings introduce a compound with strong activity against highly resistant bacterial ...

LAUSANNE, Switzerland--(BUSINESS WIRE)--Gnubiotics Sciences, a leader in biotech innovation, proudly announces the allowance of a patent from the United States Patent and Trademark Office (USPTO) ...